Fig. 2: Organoids as a supplement of the clinical treatment reference index. | Cell Death Discovery

Fig. 2: Organoids as a supplement of the clinical treatment reference index.

From: Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer

Fig. 2

A Patient-derived tumor organoids have the potential to choose therapy for the individual patient. It can provide feedback to the clinician to adjust the treatment decision based on the drug screening results. B This shows the registration numbers of ongoing clinical trials based on colorectal cancer organoids [129], including registered Clinical trials from US ClinicalTrials.gov, Chinese Clinical Trial Registry, etc [130, 131].

Back to article page